Monthly intermittent chemotherapy of chronic schizophrenic outpatients with pipothiazine palmitate.
D000328:Adult; D000553:Ambulatory Care; D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D002908:Chronic Disease; D003692:Delayed-Action Preparations; D003863:Depression / Q000139:chemically induced; D004562:Electrocardiography; D005260:Female; D005640:Follicle Stimulating Hormone / Q000378:metabolism; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000139:chemically induced; D010044:Outpatient Clinics, Hospital; D010169:Palmitic Acids / Q000008:administration & dosage / Q000009:adverse effects; D010640:Phenothiazines; D010880:Piperidines / Q000008:administration & dosage / Q000009:adverse effects; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy*; D012647:Self-Assessment; D013091:Spermatogenesis / Q000187:drug effects; D013449:Sulfonamides / Q000008:administration & dosage / Q000009:adverse effects
D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; D010169:Palmitic Acids; D010640:Phenothiazines; D010880:Piperidines; D013449:Sulfonamides; D005640:Follicle Stimulating Hormone